<DOC>
	<DOCNO>NCT00301639</DOCNO>
	<brief_summary>The specific aim study document pharmacokinetics dopamine transporter DAT receptor occupancy OROS MPH Metadate CD use PET scan C-11 Altropane ligand . We hypothesize CNS DAT occupancy OROS MPH great Metadate CD 10 hour administration .</brief_summary>
	<brief_title>A PET Study Examining Pharmacokinetics Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations Methylphenidate Adults</brief_title>
	<detailed_description>OROS-MPH 's pharmacokinetic profile use increase delivery MPH day ( ascend pharmacokinetic curve ) . It design replace IR-MPH TID treatment . Another new long-acting formulation Metadate CD . Metadate CD consist capsule two type bead . It design replace IR-MPH BID treatment . The main target MPH brain dopamine transporter ( DAT ) . We exquisitely sensitive methodology measure DAT occupancy use C-11 Altropane Positron Emission Tomography ( PET ) . The time course decay C-11 Altropane permit repeat imaging , thus allow documentation pharmacokinetics DAT receptor occupancy .</detailed_description>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Signed write informed consent participate study . 2 . Age : 18 55 3 . If female , nonpregnant , nonnursing , use adequate form birth control negative serum pregnancy test . 4 . Supine stand blood pressure within range 110/60 150/90 mmHg . 5 . Heart rate , rest 5 minute , within range 4690 beats/min . 6 . Subjects within 20 % ideal weight height . 7 . Right hand . 1 . Diagnosis psychotic disorder , bipolar disorder , severe depression , severe anxiety , Autism . Subjects mild mood , oppositional , conduct , anxiety disorder may permit participate consider appropriate investigator . 2 . Scores Baseline Scales : Hamilton Depression Scale &gt; 17 ( possible 67 21item scale ) ( Hamilton 1960 ) Beck Depression Inventory &gt; 19 ( possible 63 21item scale ) ( Beck et al 1961 ) Hamilton Anxiety Scale &gt; 21 ( possible 56 14item scale ) ( Hamilton 1959 ) 3 . Tics Tourette 's Syndrome . 4 . Diagnosis ADHD 5 . History head trauma loss consciousness , organic brain disorder , seizure , neurosurgical intervention . 6 . Any clinically significant chronic medical condition , judgment investigator . 7 . Mental impairment evidence I.Q . &lt; 75 . 8 . Exposure dopamine receptor antagonist within previous three ( 3 ) month . 9 . Exposure radiopharmaceutical within four ( 4 ) week prior PET scan . 10 . Subjects receive psychotropic medication . 11 . Any clinically significant abnormality screen laboratory test , vital sign , 12lead ECG , outside normal limit . 12 . Any woman childbearing potential seek become pregnant suspect may pregnant . 13 . Subjects know recent history ( within past six ( 6 ) month ) illicit drug alcohol dependence . 14 . Subjects diagnose glaucoma . 15 . Subjects risk MPH toxicity ( e.g . individual arrhythmias , coronary artery disease , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>